Wilting I, Baumgarten R, Movig KL, et al. MR findings of lithium-related kidney disease: preliminary observations in four patients.
Roque A, Herédia V, Ramalho M, de Campos R, Ferreira A, Azevedo R, et al. Chronic lithium nephropathy: MR imaging for diagnosis. Lithium effect on renal glomerular function in individuals with intellectual disability. The McGill Geriatric Lithium-Induced Diabetes Insipidus Clinical Study (McGLIDICS). Rej S, Segal M, Low NC, Mucsi I, Holcroft C, Shulman K, et al. Neurotoxicity in chronic lithium poisoning. Hlaing PM, Isoardi KZ, Page CB, Pillans P. Lithium Use, but Not Valproate Use, Is Associated With a Higher Risk of Chronic Kidney Disease in Older Adults With Mental Illness. Rej S, Herrmann N, Shulman K, Fischer HD, Fung K, Harel Z, et al. Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. 2 (12):1075-83.Īprahamian I, Santos FS, dos Santos B, Talib L, Diniz BS, Radanovic M, et al.
Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study. 13:12.Ĭlos S, Rauchhaus P, Severn A, Cochrane L, Donnan PT. Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. 386 (9992):461-8.īocchetta A, Ardau R, Fanni T, Sardu C, Piras D, Pani A, et al. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Shine B, McKnight RF, Leaver L, Geddes JR. Chronic kidney disease in lithium-treated patients, incidence and rate of decline. Van Alphen AM, Bosch TM, Kupka RW, Hoekstra R. Late onset nephrogenic diabetes insipidus following cessation of lithium therapy.
Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification. Acute lithium intoxication and neuroleptic malignant syndrome. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. Markowitz GS, Radhakrishnan J, Kambham N, et al. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Disordered water channel expression and distribution in acquired nephrogenic diabetes insipidus. Marples D, Frokiaer J, Knepper MA, et al. Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation. Nielsen J, Hoffert JD, Knepper MA, et al. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity. Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers. Altered expression of selected genes in kidney of rats with lithium-induced NDI. Persistent nephrogenic diabetes insipidus following lithium therapy. Lithium-induced nephrogenic diabetes insipidus. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Garofeanu CG, Weir M, Rosas-Arellano MP, et al. Lithium-induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD. Lithium evokes a more pronounced natriuresis when administered orally than when given intravenously to salt-depleted rats. Dysregulation of renal aquaporins and epithelial sodium channel in lithium-induced nephrogenic diabetes insipidus. Nielsen J, Kwon TH, Christensen BM, et al. 19 (1):305.īaird-Gunning J, Lea-Henry T, Hoegberg LCG, Gosselin S, Roberts DM.
0 kommentar(er)
